장경원 (성균관대학교 의과대학, 삼성서울병원)님 | 한빛사연구자 > 한빛사

성균관대학교 의과대학, 삼성서울병원

최종업데이트 2024.10.30.

Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease
- Cell, October 13, 2025 | https://doi.org/10.1016/j.cell.2025.09.010
- 2025-10
- 의약학
- 한빛사논문
Long-term clinical outcome of a novel bilateral capsulotomy with focused ultrasound in refractory obsessive-compulsive disorder treatment
- Mol. Psychiatr., Oct 28 2024, | https://doi.org/10.1038/s41380-024-02799-9
- 2024-10
- 의약학
- 한빛사논문
One-year Outcomes of Deep Brain Stimulation in Refractory Tourette Syndrome in Korea
- Psychiatry Clin. Neurosci., 10 August 2023 | https://doi.org/10.1111/pcn.13584
- 2023-08
- 의약학
- 한빛사논문

연구자 ID

저자논문